XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity of WSFS
Common Stock
Capital in Excess of Par Value
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020     57,575,783          
Beginning balance at Dec. 31, 2020 $ 1,789,480 $ 1,791,726 $ 576 $ 1,053,022 $ 56,007 $ 977,414 $ (295,293) $ (2,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 271,605 271,442       271,442   163
Other comprehensive (loss) income (93,775) (93,775)     (93,775)      
Cash dividend (24,242) (24,242)       (24,242)    
Issuance of common stock including proceeds from exercise of common stock options (in shares)     119,893          
Issuance of common stock including proceeds from exercise of common stock options 1,522 1,522 $ 1 1,521        
Stock-based compensation expense 5,694 5,694   5,694        
Repurchases of common stock [1] (13,268) (13,268)   (1,240)     (12,028)  
Ending balance (in shares) at Dec. 31, 2021     57,695,676          
Ending balance at Dec. 31, 2021 1,937,016 1,939,099 $ 577 1,058,997 (37,768) 1,224,614 (307,321) (2,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 222,648 222,375       222,375   273
Other comprehensive (loss) income (638,076) (638,076)     (638,076)      
Cash dividend (35,746) (35,746)       (35,746)    
Issuance of common stock including proceeds from exercise of common stock options (in shares)     109,473          
Issuance of common stock including proceeds from exercise of common stock options 3,179 3,179 $ 1 3,178        
Distributions to noncontrolling shareholders (504)             (504)
Issuance of common stock in acquisition of BMT (in shares)     18,116,848          
Issuance of common stock in acquisition of BMT 908,016 908,016 $ 181 907,835        
Noncontrolling interest assumed in acquisition (913)             (913)
Stock-based compensation expense 6,349 6,349   6,349        
Repurchases of common stock [1] (200,083) (200,083)   (2,149)     (197,934)  
Ending balance (in shares) at Dec. 31, 2022     75,921,997          
Ending balance at Dec. 31, 2022 2,201,886 2,205,113 $ 759 1,974,210 (675,844) 1,411,243 (505,255) (3,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 269,025 269,156       269,156   (131)
Other comprehensive (loss) income 81,853 81,853     81,853      
Cash dividend (36,742) (36,742)       (36,742)    
Issuance of common stock including proceeds from exercise of common stock options (in shares)     173,097          
Issuance of common stock including proceeds from exercise of common stock options 3,298 3,298 $ 2 3,296        
Distributions to noncontrolling shareholders (4,463)             (4,463)
Stock-based compensation expense 9,605 9,605   9,605        
Repurchases of common stock [1] (54,647) (54,647)   (2,365)     (52,282)  
Ending balance (in shares) at Dec. 31, 2023     76,095,094          
Ending balance at Dec. 31, 2023 $ 2,469,815 $ 2,477,636 $ 761 $ 1,984,746 $ (593,991) $ 1,643,657 $ (557,537) $ (7,821)
[1] Repurchase of common stock for the years ended December 31, 2023, 2022 and 2021 included 1,247,178, 4,151,117 and 267,309 shares repurchased, respectively, in connection with the Company's share buyback program approved by the Board of Directors, and 45,489, 113,039 and 31,188 shares withheld, respectively, to cover tax liabilities.